• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《肝硬化肝性脑病诊治指南》

Chinese guidelines on management of hepatic encephalopathy in cirrhosis.

机构信息

Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.

Hepatology and Digestion Center, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.

出版信息

World J Gastroenterol. 2019 Sep 28;25(36):5403-5422. doi: 10.3748/wjg.v25.i36.5403.

DOI:10.3748/wjg.v25.i36.5403
PMID:31576089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6767982/
Abstract

The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of hepatic encephalopathy (HE) including minimal hepatic encephalopathy (MHE) and overt hepatic encephalopathy, emphasizing the importance on screening MHE in patients with end-stage liver diseases. The guidelines emphasized that early identification and timely treatment are the key to improve the prognosis of HE. The principles of treatment include prompt removal of the cause, recovery of acute neuropsychiatric abnormalities to baseline status, primary prevention, and secondary prevention as soon as possible.

摘要

中国肝炎学会基于已发表的证据和专家共识,制定了目前关于肝硬化性肝性脑病管理的指南。这些指南提供了肝性脑病(HE)的诊断和管理建议,包括轻微肝性脑病(MHE)和显性肝性脑病,并强调了在终末期肝病患者中筛查 MHE 的重要性。该指南强调,早期识别和及时治疗是改善 HE 预后的关键。治疗原则包括迅速去除病因、使急性神经精神异常恢复到基线状态、进行初级预防和尽快进行二级预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e059/6767982/4734e673ed4b/WJG-25-5403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e059/6767982/4734e673ed4b/WJG-25-5403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e059/6767982/4734e673ed4b/WJG-25-5403-g001.jpg

相似文献

1
Chinese guidelines on management of hepatic encephalopathy in cirrhosis.《肝硬化肝性脑病诊治指南》
World J Gastroenterol. 2019 Sep 28;25(36):5403-5422. doi: 10.3748/wjg.v25.i36.5403.
2
[Guidelines on the management of hepatic encephalopathy in cirrhosis].[肝硬化肝性脑病管理指南]
Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):705-718. doi: 10.3760/cma.j.issn.0578-1426.2018.10.004.
3
[Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis].[肝硬化肝性脑病的诊断和管理指南]
Zhonghua Gan Zang Bing Za Zhi. 2018 Oct 20;26(10):721-736. doi: 10.3760/cma.j.issn.1007-3418.2018.10.001.
4
[Chinese guidelines on the management of hepatic encephalopathy in cirrhosis (2024)].[肝硬化肝性脑病管理中国指南(2024年)]
Zhonghua Gan Zang Bing Za Zhi. 2024 Sep 20;32(9):799-812. doi: 10.3760/cma.j.cn501113-20240630-00309.
5
[Clinical guidelines on nutrition in end-stage liver disease].[终末期肝病营养临床指南]
Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):330-342. doi: 10.3760/cma.j.issn.1007-3418.2019.05.003.
6
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.目前针对肝硬化患者轻微肝性脑病的治疗方法。
World J Gastroenterol. 2021 Jun 14;27(22):3050-3063. doi: 10.3748/wjg.v27.i22.3050.
7
[Update points for the 2022 edition of the European Association for the Study of Liver Diseases Clinical Practice Guidelines for the Management of Hepatic Encephalopathy and comparison with China's 2018 edition guidelines].[欧洲肝脏研究学会肝性脑病管理临床实践指南2022版更新要点及与中国2018版指南的比较]
Zhonghua Gan Zang Bing Za Zhi. 2023 Sep 20;31(9):921-927. doi: 10.3760/cma.j.cn501113-20221111-00560.
8
Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.演变的概念:轻微肝性脑病的负面影响和肝硬化患者预防的作用。
Clin Ther. 2013 Sep;35(9):1458-73. doi: 10.1016/j.clinthera.2013.07.421. Epub 2013 Aug 22.
9
Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?如果我们不对肝硬化患者进行轻微肝性脑病筛查,这算是医疗失误吗?
Rev Esp Enferm Dig. 2002 Sep;94(9):544-57.
10
Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.肝硬化患者基于人群队列的肝性脑病的预后。
Aliment Pharmacol Ther. 2020 Jun;51(12):1397-1405. doi: 10.1111/apt.15749. Epub 2020 May 3.

引用本文的文献

1
[Protective effect of knock-down the expression of gene on early liver injury in CCl-induced mouse model of liver fibrosis].[敲低基因表达对四氯化碳诱导的小鼠肝纤维化模型早期肝损伤的保护作用]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):727-734. doi: 10.19723/j.issn.1671-167X.2025.04.016.
2
Early prediction of adverse outcomes in liver cirrhosis using a CT-based multimodal deep learning model.使用基于CT的多模态深度学习模型对肝硬化不良结局进行早期预测。
Abdom Radiol (NY). 2025 Jun 27. doi: 10.1007/s00261-025-05045-0.
3
Early prediction of invasive fungal infection risk in acute-on-chronic liver failure: a prediction model based on admission indicators.

本文引用的文献

1
A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism.一项评估溴隐亭治疗肝硬化伴发肝性帕金森病患者疗效的双盲随机对照试验。
Liver Int. 2019 Apr;39(4):684-693. doi: 10.1111/liv.14024. Epub 2019 Feb 4.
2
Aberrant topological organization of the functional brain network associated with prior overt hepatic encephalopathy in cirrhotic patients.与肝硬化患者先前显性肝性脑病相关的功能性大脑网络的异常拓扑组织。
Brain Imaging Behav. 2019 Jun;13(3):771-780. doi: 10.1007/s11682-018-9896-y.
3
[Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis].
慢性肝衰竭急性发作时侵袭性真菌感染风险的早期预测:基于入院指标的预测模型
BMC Microbiol. 2025 Mar 12;25(1):131. doi: 10.1186/s12866-025-03819-6.
4
Efficacy and safety of rifaximin for the prophylaxis of hepatic encephalopathy: A meta-analysis.利福昔明预防肝性脑病的疗效与安全性:一项荟萃分析。
Medicine (Baltimore). 2025 Jan 31;104(5):e39905. doi: 10.1097/MD.0000000000039905.
5
Predictive Factors and Nomogram for Spontaneous Bacterial Peritonitis in Decompensated Cirrhosis Among the Elderly.老年失代偿期肝硬化患者自发性细菌性腹膜炎的预测因素及列线图
J Inflamm Res. 2024 Dec 12;17:10901-10911. doi: 10.2147/JIR.S484629. eCollection 2024.
6
D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy.D-二聚体是慢性肝衰竭和肝性脑病患者1年死亡率的预后标志物。
Hepatol Forum. 2024 Sep 11;5(4):193-197. doi: 10.14744/hf.2023.2023.0065. eCollection 2024.
7
Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.经颈静脉肝内门体分流术后肝性脑病:预测评估的现状与前景
Comput Struct Biotechnol J. 2024 Jul 10;24:493-506. doi: 10.1016/j.csbj.2024.07.008. eCollection 2024 Dec.
8
Microbiota-gut-liver-brain axis and hepatic encephalopathy.微生物群-肠-肝-脑轴与肝性脑病
Microbiome Res Rep. 2024 Jan 25;3(2):17. doi: 10.20517/mrr.2023.44. eCollection 2024.
9
Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathy.基于回归的数字连接测试 A 和数字符号测试的中文版常模用于诊断轻微肝性脑病。
Sci Rep. 2024 Feb 18;14(1):4005. doi: 10.1038/s41598-024-54696-4.
10
The Mechanism of Hepatic Encephalopathy Induced by Thioacetamide Based on Metabolomics and Proteomics: A Preliminary Study.基于代谢组学和蛋白质组学的硫代乙酰胺诱导肝性脑病的机制:初步研究。
Int J Mol Sci. 2023 Dec 24;25(1):284. doi: 10.3390/ijms25010284.
扶正化瘀胶囊对肝硬化患者生存率的影响
Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):834-840. doi: 10.3760/cma.j.issn.1007-3418.2017.11.007.
4
The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.GP73 在免疫介导的慢性肝病中的临床意义:实验数据和文献综述。
Clin Rev Allergy Immunol. 2018 Apr;54(2):282-294. doi: 10.1007/s12016-017-8655-y.
5
Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.幽门螺杆菌与肝性脑病风险的关联
Dig Dis Sci. 2017 Dec;62(12):3614-3621. doi: 10.1007/s10620-017-4834-1. Epub 2017 Nov 8.
6
[Guidelines on the management of ascites and complications in cirrhosis].[肝硬化腹水及并发症管理指南]
Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):664-677. doi: 10.3760/cma.j.issn.1007-3418.2017.09.006.
7
Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.2016年国际多发性遗传性骨软骨瘤会议关于其发病机制及可能治疗方法的进展
Connect Tissue Res. 2018 Jan;59(1):85-98. doi: 10.1080/03008207.2017.1394295. Epub 2017 Nov 3.
8
Multi-Sensory Integration Impairment in Patients with Minimal Hepatic Encephalopathy.轻微肝性脑病患者的多感觉整合障碍。
Sci Rep. 2017 Nov 2;7(1):14947. doi: 10.1038/s41598-017-15113-1.
9
The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.通过一项随机对照多模态干预验证的轻微肝性脑病连续反应时间测试:一项初步研究。
PLoS One. 2017 Oct 11;12(10):e0185412. doi: 10.1371/journal.pone.0185412. eCollection 2017.
10
Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. covert 型肝性脑病自然史:366 例肝硬化患者的观察性研究。
World J Gastroenterol. 2017 Sep 14;23(34):6321-6329. doi: 10.3748/wjg.v23.i34.6321.